WebEnliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. Boulder, Colorado, United States 11-50 Series B Private www.enliventherapeutics.com/ … WebFeb 23, 2024 · February 23, 2024. Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million.
Portfolio – 5AM Ventures
WebOct 17, 2024 · Last week was a big one for Boulder-based oncology drug developer Enliven Therapeutics Inc., which inked a merger deal that will take the company public and result in $165 million in new investment. Web1 day ago · Enliven Therapeutics Inc. is a clinical-stage precision oncology company focused on the discovery and development of small molecule kinase inhibitors. The Company's lead product candidate... react usereducer side effects
Enliven Therapeutics, Inc. Common Stock (ELVN) Stock Price, …
WebApr 6, 2024 · Enliven Therapeutics, Inc., formerly Imara, Inc., is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with... WebMar 31, 2024 · Enliven Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $25.34 on 02/24/23, with the lowest value was $3.90 for the same time period, recorded on 04/13/22. Top 5 EV Tech Stocks to Buy for 2024 WebApr 11, 2024 · Enliven Therapeutics, Inc. (ELVN) (Delayed Data from NSDQ) $20.72 USD -0.73 (-3.40%) Updated Apr 10, 2024 04:00 PM ET After-Market: $20.45 -0.27 (-1.30%) 7:58 PM ET Add to portfolio Zacks Rank:... react useref assign value